IGF2BP2, an m6A “reader,” is upregulated in head and neck squamous cell carcinoma (HNSC), where it correlates with poor prognosis and regulates pathways related to cell proliferation and immune modulation [109]. Here, IGF2BP2 is linked to head and neck squamous cell carcinoma.